Impact of Atrial Fibrillation Termination Site and Termination Mode in Catheter Ablation on Arrhythmia Recurrence
|
|
- Kristin Simpson
- 5 years ago
- Views:
Transcription
1 78 MIYAZAKI S et al. Circulation Journal ORIGINAL ARTICLE Official Journal of the Japanese Circulation Society Arrhythmia/Electrophysiology Impact of Atrial Fibrillation Termination Site and Termination Mode in Catheter Ablation on Arrhythmia Recurrence Shinsuke Miyazaki, MD; Hiroshi Taniguchi, MD; Shigeki Kusa, MD; Takashi Uchiyama, MD; Hiroaki Nakamura, MD; Hitoshi Hachiya, MD; Kenzo Hirao, MD; Yoshito Iesaka, MD Background: Although atrial fibrillation (AF) termination has been reported as a predictor of clinical outcome after persistent AF (PsAF) ablation, the relationship between AF termination site and mode and clinical outcome has not been fully evaluated. Methods and Results: A total of 135 patients (62±9 years) underwent their first ablation procedure for PsAF (76 longstanding PsAF). With an endpoint of AF termination, the ablation procedure was performed sequentially in the following order: pulmonary vein (PV) antrum isolation, and left atrial and right atrial substrate modification. AF termination was achieved in 69 patients (51%; 24 at the PV antrum, and 45 in the atrium; direct conversion to sinus rhythm in 21, and atrial tachycardia [AT] in 48). With a mean of 1.7±0.7 procedures/patient, 100 patients (74%) were free from atrial tachyarrhythmia (ATa) during a median of 15.0 months of follow-up. During the initial procedure, the AF termination site (atrium vs. PV antrum, hazard ratio [HR], 1.38; 95% confidence interval [CI]: ; no termination vs. PV antrum, HR, 2.32; 95% CI: ; P=0.023) and mode (AT vs. sinus rhythm, HR, 1.47; 95% CI: ; no termination vs. sinus rhythm, HR, 2.38; 95% CI: ; P=0.017) were independent predictors of ATa recurrence after the last ablation procedure. Conclusions: The site and mode of AF termination during the index ablation procedure predict ATa recurrence following multiple catheter ablation procedures for PsAF. (Circ J 2014; 78: 78 84) Key Words: Atrial fibrillation; Catheter ablation; Persistent atrial fibrillation Catheter ablation is an established therapy for drug-resistant atrial fibrillation (AF), 1,2 and pulmonary vein antrum isolation (PVAI) has become a widely accepted strategy. 3 6 Although the ablation strategy for persistent AF (PsAF) and procedural endpoint remain controversial, several reports have shown that AF termination during the procedure leads to a better clinical outcome The relationship between AF termination site/mode and clinical outcome, however, has not been fully evaluated. The aim of this study was to investigate the clinical impact of AF termination site and termination mode during PsAF ablation on clinical outcome. Editorial p 57 Methods The study consisted of 135 consecutive patients undergoing catheter ablation of PsAF (Table 1) at Tsuchiura Kyodo Hospital. AF was defined as persistent (sustained beyond 7 days or lasting <7 days but necessitating cardioversion) or longstanding persistent (continuous AF >1 year in duration) according to the HRS/EHRA/ECAS 2012 Consensus Statement on Catheter and Surgical Ablation of AF. 14,15 All patients were in AF at the beginning of the procedure and provided written informed consent prior to the procedure. Electrophysiological Study All anti-arrhythmic medications were discontinued at least 5 half-lives prior to the ablation. All patients were anti-coagulated with warfarin for at least 1 month before the procedure, and therapeutic anti-coagulation was maintained with i.v. heparin following discontinuation of warfarin 3 days prior to the intervention. Transesophageal echocardiography was performed within 24 h before the procedure to exclude any left atrial (LA) thrombi. Warfarin was restarted on the day of the procedure. Enhanced cardiac computed tomography was performed for Received July 1, 2013; revised manuscript received August 29, 2013; accepted September 26, 2013; released online November 2, 2013 Time for primary review: 21 days Cardiovascular Center, Tsuchiura Kyodo Hospital, Tsuchiura (S.M., H.T., S.K., T.U., H.N., H.H., Y.I.); Heart Rhythm Center, Tokyo Medical and Dental University, Tokyo (K.H.), Japan Mailing address: Shinsuke Miyazaki, MD, Cardiology Division, Cardiovascular Center, Tsuchiura Kyodo Hospital, 11-7 Manabeshinmachi, Tsuchiura , Japan. mshinsuke@k3.dion.ne.jp ISSN doi: /circj.CJ All rights are reserved to the Japanese Circulation Society. For permissions, please cj@j-circ.or.jp
2 AF Termination Site/Mode and Arrhythmia Recurrence 79 the evaluation of the relevant cardiac anatomy before the procedure. Surface electrocardiogram (ECG) and bipolar intracardiac electrograms were continuously monitored and stored on a computer-based digital recording system (LabSystem PRO; Bard Electrophysiology, Lowell, MA, USA). Bipolar electrograms were filtered from 30 to 500 Hz. A 7-Fr 20-pole or 14-pole 1-site mapping catheter (Irvine Biomedical, Irvin, CA, USA) was inserted through the right jugular vein and positioned in the coronary sinus for pacing, recording and internal cardioversion. The electrophysiological study was performed under mild sedation with pentazocine and hydroxyzine pamoate. Catheter Ablation Protocol The details of the ablation protocol have been reported previously. 6,16 After 1 transseptal puncture, 1 long sheath (SL0; AF Division, St. Jude Medical, Minneapolis, MN, USA) was introduced into both superior PV. Pulmonary venography during ventricular pacing and contrast esophagography were done to obtain the relative locations of the PV ostia vis-a-vis the esophagus. A 100-IU/kg body weight of heparin was given following the transseptal puncture, and heparinized saline was additionally infused to maintain the activated clotting time at s. Two decapolar circular mapping catheters (Lasso; Biosense Webster, Diamond Bar, CA, USA) were placed in the superior and inferior PV, and the left- and right-sided ipsilateral PV were circumferentially ablated under the guidance of a 3-D mapping system (CARTO3; Biosense Webster). Posteriorly, ablation was performed anatomically in the LA, approximately 1 3 cm from the PV ostia. Anteriorly, ablation was performed on the edge of the left PV guided by early PV potentials. The electrophysiological endpoint of the PVAI was the achievement of bidirectional conduction block between the LA and PV, and the anatomic endpoint was the creation of a complete continuous circumferential lesion around the ipsilateral veins. 17 Radiofrequency (RF) current was delivered point-by-point for 30 s with a 3.5-mm externally irrigated-tip quadripolar ablation catheter (Thermocool; Biosense Webster) with a power of up to 35 W, target temperature 38 C and irrigation rate of 30 ml/min. The power was limited to 20 W on the posterior wall close to the esophagus. The substrate modification, when AF persisted after the PVAI, was performed sequentially using a linear defragmentation approach in both atria. 16 The endpoint of the substrate ablation was the termination of AF and restoration of sinus rhythm by ablation. If AF continued after this step, the patients underwent internal electrical cardioversion. No anti-arrhythmic drugs were given during the procedure. Termination of AF was defined as conversion of AF to sinus rhythm directly or via 1 or more intermediate atrial tachycardias (AT). If AF was converted to an AT, it was mapped and ablated using 3-D activation mapping and entrainment maneuvers. 18,19 When a critical isthmus of a macroreentrant circuit was identified, the lesions were deployed to achieve complete bidirectional conduction block. 20,21 After restoration of sinus rhythm, a cavotricuspid isthmus line was created with an endpoint of bidirectional conduction block in all patients. 22 Repeat Procedure In patients with recurrence of atrial tachyarrhythmia (ATa), the PVAI was evaluated first. In the presence of conduction recovery, re-isolation of the PV was performed. In patients in whom the baseline rhythm was sinus rhythm, the previous lesion set was evaluated and completed. Then, AT was induced by programmed stimulation if the type of recurrence was AT. Induction testing was not performed if the type of recurrence was Table 1. Clinical Characteristics (n=135) Age (years) 62±9 Male 115 (85) Type of AF Persistent 59 (44) Longstanding persistent 76 (56) Structural heart disease 12 (9) Cardiomyopathy 6 (5) Valvular disease 4 (3) Coronary disease 2 (2) Hypertension 69 (51) AF duration (months) 48 (19 96) AF lasting duration (months) 24 (6 54) LA diameter (mm) 47±5 LVEF (%) 61±10 CHADS2 1.1±1.1 CHA2DS2-VASc 1.7±1.3 Data given as mean ± SD, n (%) or median (IQR). AF, atrial fibrillation; LA, left atrium; LVEF, left ventricular ejection fraction. AF. Patients in whom the baseline rhythm was PsAF underwent repeat stepwise ablation with the same strategy as in the initial procedure. If stable AT was present, its mechanism was deduced using 3-D activation and entrainment mapping. Follow-up Patients underwent continuous ECG monitoring as inpatients for 3 days following the procedure. The first outpatient clinic visit was 3 weeks after the ablation procedure. The follow-up visits consisted of a clinical interview, ECG, and 24-h Holter monitoring every 3 months at the cardiology clinic. Anti-arrhythmic drugs were prescribed during the first 3 months for a blanking period. If any symptoms suggestive of an arrhythmia occurred between the scheduled visits, the patients were asked to come to the emergency department, and a 12-lead ECG or 24-h Holter monitoring, and/or 1-month-event recording were performed in order to define the cause of the symptoms. For the detection of any asymptomatic events, we used an external loop recorder (Spider Flash, Sorin, France), which enabled the automatic detection of ATa for 14 consecutive days. Recurrent AF was defined according to the patient s symptoms, and/or if an episode of AF lasting >30 s was documented on ECG. Repeat procedure was strongly recommended for the patients with documented recurrent ATa. Statistical Analysis Continuous data are expressed as mean ± SD for normally distributed variables or as the median (interquartile range [IQR]; 25th 75th percentiles) for non-normally distributed variables, and were compared using Student s t-test or Mann-Whitney U-test, respectively. Multivariate Cox method was used to determine the predictors of recurrent ATa. Variables with P<0.05 on univariate analysis were included in the multivariate Cox regression model. Categorical variables were compared using the chi-squared test. P<0.05 indicated statistical significance. Kaplan-Meier analysis was used to determine the percentage of patients free from ATa. The difference in ATa-free survival was evaluated using log-rank test. The following patient and procedural variables were evaluated in association with arrhythmia freedom after the last ablation procedure: age, sex,
3 80 MIYAZAKI S et al. Figure 1. Distribution of atrial fibrillation termination site in the initial and second procedures. AW, anterior wall; CS, coronary sinus; CT, crista terminalis; FO, fossa ovalis; IVC, inferior vena cava; LA, left atrium; LAA, left atrial appendage; LAAW, left atrial anterior wall; LIPV, left inferior pulmonary vein; LSPV, left superior pulmonary vein; MA, mitral annulus; PW, posterior wall; RAA, right atrial appendage; RIPV, right inferior pulmonary vein; RSPV, right superior pulmonary vein; SVC, superior vena cava. Figure 2. Mechanisms of the mappable atrial tachycardia (AT) in the initial and second procedures. CTI, cavotricuspid isthmusdependent AT; LA roof, left atrium roof-dependent AT; localized/focal, localized AT/focal AT; macro, macroreentrant AT; MI, mitral isthmus-dependent AT. All other acronyms as in Figure 1.
4 AF Termination Site/Mode and Arrhythmia Recurrence 81 Table 2. Initial Procedure Result vs. Second Procedure Baseline Baseline rhythm in the second procedure AF AT Sinus rhythm Termination at the PV antrum Termination at the atrium Conversion to sinus rhythm Conversion to AT No AF termination AT, atrial tachycardia; PV, pulmonary vein. Other abbreviation as in Table 1. Figure 3. (A) Significant difference in number of patients free of atrial tachyarrhythmia (ATa; log-rank test, P=0.013) after the last ablation procedure with regard to atrial fibrillation (AF) termination site (Kaplan-Meier analysis). (B) Significant difference in number of patients free of ATa (log-rank test, P=0.018) after the last ablation procedure with regard to AF termination mode (Kaplan- Meier analysis). AT, atrial tachycardia. presence of structural heart disease, hypertension, duration of PsAF, LA diameter, left ventricular ejection fraction, CHADS2 score, CHA2DS2-VASc score, and the AF termination by catheter ablation at the index procedure. Subsequently, the AF termination site and the mode were included in the univariate and multivariate Cox regression model instead of AF termination to determine the impact on the clinical outcome. Results Ablation Procedure and Clinical Outcome PVAI with bidirectional conduction block of the cavotricuspid isthmus was successfully achieved in all patients. In 69 of 135 patients (51%), AF was terminated by catheter ablation alone, while cardioversion was required in the remaining 66 patients. Overall, AF was terminated at the PV antrum in 24 (35%) and in the atrium in 45 patients (LA, n=35; right atrium [RA], n=10; 65%; Figure 1). AF converted to AT in 48 patients (70%), and to sinus rhythm in 21 (30%). Among 24 patients with AF termination during the PVAI, AF converted to AT and sinus rhythm directly in 12 patients each. A total of 39 AT were mappable (Figure 2). In 79 patients (59%), a second procedure was performed at a median of 4 months (IQR, 3 7 months) after the initial procedure. The baseline rhythm was AF, AT or sinus rhythm in 23 (29%), 21 (27%) and 35 (44%), respectively. Recovered PV conduction was found in 60 patients (76%); conduction gaps were located along the right-sided PV lesions in 43 patients and the left-sided PV lesions in 44 patients. Among the 23 patients in whom the baseline rhythm was AF, AF converted to AT during the RF applications at the PV antrum and atrium in 2 (9%) and 7 (30%), respectively (Figure 1). Direct conversion to sinus rhythm was not observed in any patients, and the remaining 14 (61%) required electrical cardioversion to restore sinus rhythm after a sequential substrate modification. The correlation between the results of the initial ablation procedure and the baseline rhythm in the second procedure is shown in Table 2. Termination mode correlated with baseline rhythm in the second procedure. AF was terminated again during PVAI in 2 patients in whom AF was terminated during the PVAI in the initial procedure. Among the patients in whom sinus rhythm was directly restored in the initial procedure, only 1 had AT (localized AT in the LA appendage) in the second procedure. The mechanism of the mappable AT is shown in Figure 2. In 12 patients (9%), a third procedure was performed at a median of 12 months after the initial procedure. Recovered PV conduction was found in 2 patients. In 2 (2%), a fourth procedure was performed at a median of 22.5 months after the initial procedure. No recovered PV conduction was found. At a median follow-up of 15 months (IQR, months) and after a mean of 1.7±0.7 procedures per patient, 100 patients (74%; including 15% receiving an anti-arrhythmic drug) were free from ATa.
5 82 MIYAZAKI S et al. Table 3. Predictors of ATa Recurrence After Last Ablation Procedure Univariate Multivariate HR P-value 95% CI HR P-value 95% CI Age (years) Sex (female) Hypertension (0) Structural heart disease (0) AF lasting duration AF type (PsAF) LA diameter LVEF CHADS CHA2DS2-VASc AF termination site PV antrum Atrium No termination AF termination mode Sinus rhythm AT No termination ATa, atrial tachyarrhythmia; CI, confidence interval; HR, hazard ratio; PsAF, persistent AF. Other abbreviations as in Tables 1,2. Figure 4. During the second ablation procedure, pulmonary vein (PV) reconnection was significantly more prevalent for patients in whom atrial fibrillation terminated around the PV antrum than elsewhere or nowhere in the atrium in the initial procedure (100% vs. 70% vs. 70%; P=0.01). On Kaplan-Meier analysis, the estimated probability of arrhythmia-free survival at 1 year and 2 years of follow-up after the last procedure was 75.9% and 64.3%, respectively. In total, 228 procedures (median, 2; IQR, 1 2) were performed in 135 patients. In the present study there were 11 major complications (5%). Cardiac tamponade and pericarditis were observed in 3 patients and in 1 patient, respectively. The tamponade was managed successfully by percutaneous pericardiocentesis. Three patients experienced transient gastric hypomotility. Three patients developed transient right phrenic paresis. One patient experienced congestive heart failure requiring a prolongation of hospitalization. Termination Site and ATa Recurrence ATa recurrence after the last procedure was significantly lower in patients in whom AF terminated during PV antrum ablation vs. during an atrial substrate modification (Figure 3A; log-rank, P=0.04), but this difference was not observed after the index procedure. Also, there was no significant difference in ATa recurrence after the last procedure between the patients with AF termination during LA vs. RA ablation (log-rank, P=0.43). On multivariate Cox regression analysis, AF termination site in the initial procedure (atrium vs. PV antrum: hazard ratio [HR], 1.38; 95% confidence interval [CI]: ; no termination vs. PV antrum: HR, 2.32; 95% CI: ; P=0.023) was
6 AF Termination Site/Mode and Arrhythmia Recurrence 83 an independent predictor of ATa recurrence after the last ablation procedure (Table 3). During the second ablation procedure, PV reconnections occurred significantly more often in patients in whom AF terminated around the PV antrum than elsewhere or nowhere in the atrium at initial procedure (100% vs. 70% vs. 70%, P=0.01; Figure 4). Termination Mode and ATa Recurrence The patients with direct restoration of sinus rhythm from AF in the initial procedure had a significantly lower ATa recurrence rate after the last procedure than those in whom AF converted to AT (Figure 3B). The difference, however, was not significant when comparison was done at the initial procedure. On multivariate Cox regression analysis, mode of AF termination in the initial procedure (AT vs. sinus rhythm: HR, 1.47; 95% CI: ; no termination vs. sinus rhythm: HR, 2.38; 95% CI: ; P=0.017) was an independent predictor of ATa recurrence after the last ablation procedure (Table 3). There was a significant difference in the rate of direct conversion to sinus rhythm between the patients with different termination sites (PV antrum vs. atrium, P=0.01). Discussion This study analyzed the impact of AF termination site and mode on arrhythmia recurrence after catheter ablation of PsAF. First, it was found that AF termination site was an independent predictor of arrhythmia recurrence after multiple AF ablation procedures. AF termination during PV antrum ablation in the initial procedure predicted a better clinical outcome. Second, AF termination mode was an independent predictor of clinical outcome after multiple AF ablation procedures. Direct conversion to sinus rhythm during the initial AF ablation procedure predicted a better clinical outcome. AF Termination During Catheter Ablation PsAF is a complex arrhythmia and several catheter ablation strategies have been proposed. 7 13,16,23 25 PVAI is the first step and substrate modification the second in the vast majority of strategies. Regardless of the different ablation strategies, it has been reported that AF termination results in better clinical outcome in patients with PsAF, which was also observed in the present study. This is reasonable because termination of AF can be interpreted as complete suppression of all AF-initiating and -perpetuating mechanisms active at the time of the ablation procedure. Whether the AF termination site and termination mode affect arrhythmia recurrence, however, has not been fully evaluated. AF Termination Site and ATa Recurrence The present study showed that AF termination during PV antral ablation was associated with a better clinical outcome than termination during atrial substrate modification after multiple procedures but not after the initial procedure. Interestingly, all patients who underwent a second procedure among those with AF termination during PVAI had PV reconnections, which was a significantly higher prevalence than in the other patients. Moreover, a reconnection of both sides of the PV was more frequently observed in patients with AF termination during PVAI. These results suggest that reconnection of the PV is strongly associated with the mechanism of recurrence in these patients, and highlights the importance of durable PVAI for the cure of AF. AF Termination Mode and ATa Recurrence The present study showed that direct restoration of sinus rhythm was more commonly observed during PVAI than during atrial substrate modification, which suggests that the AF substrate is more complex in the latter patient group. Clinical outcome is better in the patients with direct restoration of sinus rhythm than in those with AF conversion into AT, but the result was similar after the initial procedure because of the high rate of early recurrence in the former group. A potential mechanism of AF conversion into AT, other than being iatrogenic because of RF-induced slow conduction or incomplete/recovered lesions, 26 may be the organization of AF by a diminution of the substrate necessary for and capable of fibrillatory conduction. Also, these organized arrhythmic sources may underlie and drive AF. AF Termination and ATa Recurrence Prior studies have shown that AF termination and the duration of AF are predictors of ATa recurrence after PsAF ablation. In this study, both AF duration and AF termination were significant univariate predictors, but AF duration was not a significant predictor on multivariate analysis. In contrast, both the AF termination site and termination mode had a significant impact on arrhythmia recurrence. Presumably they correlate with the amount of substrate better than the other clinical parameters. In this study, AF terminated most commonly during PV antral ablation. Although prior reports have shown that the success rate after PV isolation is limited, this study found that the PV antrum was an important substrate for the perpetuation of PsAF. Creating durable PVAI lesions is, therefore, important for improving clinical outcome. Study Limitations The patients own willingness to undergo repeat procedure may have influenced the clinical outcome after the last ablation procedure, but all prior published papers have the same limitation. It is difficult to determine the precise duration of incessant AF. The clinical symptoms and intermittent electrogram recordings are not completely reliable in the majority of PsAF, especially in the vast majority of longstanding PsAF. It is possible that different waiting times resulted in the different PV reconnection rates in the second procedure in each group. Finally, the mechanism of recurrent ATa was not always clarified at the repeat procedure because the ablation strategy depended on the baseline rhythm and it was sinus rhythm in the majority of patients. Conclusions The site and mode of AF termination during the index ablation procedure predict ATa recurrence following multiple catheter ablation procedures for PsAF. Acknowledgments We thank Ashok J. Shah and Mr John Martin for assistance with the manuscript. Financial support: none. Disclosures References 1. Haïssaguerre M, Shah DC, Jaïs P, Hocini M, Yamane T, Deisenhofer I, et al. Electrophysiological breakthroughs from the left atrium to the pulmonary veins. Circulation 2000; 102: Nault I, Miyazaki S, Forclaz A, Wright M, Jadidi A, Jaïs P, et al.
7 84 MIYAZAKI S et al. Drugs vs. ablation for the treatment of atrial fibrillation: The evidence supporting catheter ablation. Eur Heart J 2010; 31: Takahashi A, Iesaka Y, Takahashi Y, Takahashi R, Kobayashi K, Takagi K, et al. Electrical connections between pulmonary veins: Implication for ostial ablation of pulmonary veins in patients with paroxysmal atrial fibrillation. Circulation 2002; 105: Liu X, Dong J, Mavrakis HE, Hu F, Long D, Fang D, et al. Achievement of pulmonary vein isolation in patients undergoing circumferential pulmonary vein ablation: A randomized comparison between two different isolation approaches. J Cardiovasc Electrophysiol 2006; 17: Arentz T, Weber R, Bürkle G, Herrera C, Blum T, Stockinger J, et al. Small and large isolation areas around the pulmonary veins for treatment of atrial fibrillation? Results from a prospective randomized study. Circulation 2007; 115: Miyazaki S, Kuwahara T, Kobori A, Takahashi Y, Takei A, Sato A, et al. Long-term clinical outcome of extensive pulmonary vein isolation-based catheter ablation therapy in patients with paroxysmal and persistent atrial fibrillation. Heart 2011; 97: Haïssaguerre M, Hocini M, Sanders P, Sacher F, Rotter M, Takahashi Y, et al. Catheter ablation of long-lasting persistent atrial fibrillation: Clinical outcome and mechanisms of subsequent arrhythmias. J Cardiovasc Electrophysiol 2005; 16: O Neill MD, Wright M, Knecht S, Jais P, Hocini M, Takahashi Y, et al. Long-term follow-up of persistent atrial fibrillation ablation using termination as a procedural endpoint. Eur Heart J 2009; 30: Wright M, Haïssaguerre M, Knecht S, Matsuo S, O Neill MD, Nault I, et al. State of the art: Catheter ablation of atrial fibrillation. J Cardiovasc Electrophysiol 2008; 19: Hocini M, Nault I, Wright M, Veenhuyzen G, Narayan SM, Jaïs P, et al. Disparate evolution of right and left atrial rate during ablation of long-lasting persistent atrial fibrillation. J Am Coll Cardiol 2010; 55: Rostock T, Salukhe TV, Steven D, Drewitz I, Hoffmann BA, Bock K, et al. Long-term single- and multiple-procedure outcome and predictors of success after catheter ablation for persistent atrial fibrillation. Heart Rhythm 2011; 8: Narayan SM, Krummen DE, Shivkumar K, Clopton P, Rappel WJ, Miller JM. Treatment of atrial fibrillation by the ablation of localized sources: CONFIRM (Conventional Ablation for Atrial Fibrillation With or Without Focal Impulse and Rotor Modulation) trial. J Am Coll Cardiol 2012; 60: Haissaguerre M, Hocini M, Shah AJ, Derval N, Sacher F, Jais P, et al. Noninvasive panoramic mapping of human atrial fibrillation mechanisms: A feasibility report. J Cardiovasc Electrophysiol 2013; 24: Calkins H, Kuck KH, Cappato R, Brugada J, Camm AJ, Chen SA, et al HRS/EHRA/ECAS expert consensus statement on catheter and surgical ablation of atrial fibrillation: Recommendations for patient selection, procedural techniques, patient management and follow-up, definitions, endpoints, and research trial design: A report of the Heart Rhythm Society (HRS) Task Force on Catheter and Surgical Ablation of Atrial Fibrillation. Heart Rhythm 2012; 9: Raviele A, Natale A, Calkins H, Camm JA, Cappato R, Ann Chen S, et al; Venice Chart. Venice Chart international consensus document on atrial fibrillation ablation: 2011 update. J Cardiovasc Electrophysiol 2012; 23: Miyazaki S, Taniguchi H, Komatsu Y, Uchiyama T, Kusa S, Nakamura H, et al. Sequential biatrial linear defragmentation approach for persistent atrial fibrillation. Heart Rhythm 2013; 10: Miller MA, d Avila A, Dukkipati SR, Koruth JS, Viles-Gonzalez J, Napolitano C, et al. Acute electrical isolation is a necessary but insufficient endpoint for achieving durable PV isolation: The importance of closing the visual gap. Europace 2012; 14: Jaïs P, Matsuo S, Knecht S, Weerasooriya R, Hocini M, Sacher F, et al. A deductive mapping strategy for atrial tachycardia following atrial fibrillation ablation: Importance of localized reentry. J Cardiovasc Electrophysiol 2009; 20: Shah D. Twelve-lead ECG interpretation in a patient with presumed left atrial flutter following AF ablation. J Cardiovasc Electrophysiol 2011; 22: Jaïs P, Hocini M, Hsu LF, Sanders P, Scavee C, Weerasooriya R, et al. Technique and results of linear ablation at the mitral isthmus. Circulation 2004; 110: Hocini M, Jaïs P, Sanders P, Takahashi Y, Rotter M, Rostock T, et al. Techniques, evaluation, and consequences of linear block at the left atrial roof in paroxysmal atrial fibrillation: A prospective randomized study. Circulation 2005; 112: Shah D, Haissaguerre M, Takahashi A, Jais P, Clementy J. Differential pacing for distinguishing block from persistent conduction through an ablation line. Circulation 2000; 102: Kim YH. Catheter ablation of longstanding persistent atrial fibrillation: Are we on the right path? Circ J 2012; 76: Miyazaki S, Taniguchi H, Kusa S, Uchiyama T, Hirao K, Iesaka Y. Conduction recovery after electrical isolation of superior vena cava: Prevalence and electrophysiological properties. Circ J 2013; 77: Uchiyama T, Miyazaki S, Taniguchi H, Komatsu Y, Kusa S, Nakamura H, et al. Six-year follow-up of catheter ablation in paroxysmal atrial fibrillation. Circ J 2013; 77: Shah D, Sunthorn H, Burri H, Gentil-Baron P, Pruvot E, Schlaepfer J, et al. Narrow, slow-conducting isthmus dependent left atrial reentry developing after ablation for atrial fibrillation: ECG characterization and elimination by focal RF ablation. J Cardiovasc Electrophysiol 2006; 17:
Six-Year Follow-up of Catheter Ablation in Paroxysmal Atrial Fibrillation
2722 UCHIYAMA T et al. Circulation Journal ORIGINAL ARTICLE Official Journal of the Japanese Circulation Society http://www.j-circ.or.jp Arrhythmia/Electrophysiology Six-Year Follow-up of Catheter Ablation
More informationRole of Extended External Auto-Triggered Loop Recorder Monitoring for Atrial Fibrillation
Circulation Journal Official Journal of the Japanese Circulation Society http://www.j-circ.or.jp ORIGINAL ARTICLE Arrhythmia/Electrophysiology Role of Extended External Auto-Triggered Loop Recorder Monitoring
More informationElectrophysiological Characteristics of Atrial Tachycardia After Pulmonary Vein Isolation of Atrial Fibrillation
Circulation Journal Official Journal of the Japanese Circulation Society http://www.j-circ.or.jp Advance Publication by J-STAGE REVIEW Electrophysiological Characteristics of Atrial Tachycardia After Pulmonary
More informationPeri-Mitral Atrial Flutter with Partial Conduction Block between Left Atrium and Coronary Sinus
Accepted Manuscript Peri-Mitral Atrial Flutter with Partial Conduction Block between Left Atrium and Coronary Sinus Ryota Isogai, MD, Seiichiro Matsuo, MD, Ryohsuke Narui, MD, Shingo Seki, MD;, Michihiro
More informationSince pulmonary veins (PVs) have
Case Report Hellenic J Cardiol 2011; 52: 371-376 Left Atrial-Pulmonary Vein Reentrant Tachycardia Following Pulmonary Vein Isolation Dionyssios Leftheriotis, Feifan Ouyang, Karl-Heinz Kuck II. Med. Abteilung,
More informationCatheter ablation of atrial fibrillation: Indications and tools for improvement of the success rate of the method. Konstantinos P.
Ioannina 2015 Catheter ablation of atrial fibrillation: Indications and tools for improvement of the success rate of the method Konstantinos P. Letsas, MD, FESC SECOND DEPARTMENT OF CARDIOLOGY LABORATORY
More information480 April 2004 PACE, Vol. 27
Incremental Value of Isolating the Right Inferior Pulmonary Vein During Pulmonary Vein Isolation Procedures in Patients With Paroxysmal Atrial Fibrillation HAKAN ORAL, AMAN CHUGH, CHRISTOPH SCHARF, BURR
More informationClinical Significance of Early Recurrence After Pulmonary Vein Antrum Isolation in Paroxysmal Atrial Fibrillation
Circulation Journal Official Journal of the Japanese Circulation Society http://www.j-circ.or.jp ORIGINAL ARTICLE Arrhythmia/Electrophysiology Clinical Significance of Early Recurrence After Pulmonary
More informationCatheter ablation of AF Where do we stand, where do we go?
Catheter ablation of AF Where do we stand, where do we go? Sébastien Knecht MD, PhD Hôpital cardiologique du Haut L Evêque, Bordeaux Declaration of conflict of interest ABLATION STRATEGIES Duration proc:
More informationPulmonary vein isolation (PVI) is
Case Report Hellenic J Cardiol 2012; 53: 163-167 The Use of the Multi-Electrode Duty-Cycled Radiofrequency Ablation Catheter PVAC for the Ablation of a Left Atrial Tachycardia Dionyssios Leftheriotis 1,
More informationAF ABLATION Concepts and Techniques
AF ABLATION Concepts and Techniques Antony F Chu, M.D. Director of Complex Ablation Arrhythmia Services Section Division of Cardiology at the Rhode Island and Miriam Hospital HIGHLIGHTS The main indications
More informationDisparate Evolution of Right and Left Atrial Rate During Ablation of Long-Lasting Persistent Atrial Fibrillation
Journal of the American College of Cardiology Vol. 55, No. 10, 2010 2010 by the American College of Cardiology Foundation ISSN 0735-1097/10/$36.00 Published by Elsevier Inc. doi:10.1016/j.jacc.2009.09.060
More informationWe are IntechOpen, the world s leading publisher of Open Access books Built by scientists, for scientists. International authors and editors
We are IntechOpen, the world s leading publisher of Open Access books Built by scientists, for scientists 3,800 116,000 120M Open access books available International authors and editors Downloads Our
More informationLong Standing Persistent AF ; CPVI is enough for it
Long Standing Persistent AF ; CPVI is enough for it Kee-Joon Choi, MD University of Ulsan College of Medicine Asan Medical Center, Seoul, Korea Boston AF Symposium 2012 In a patient undergoing AF ablation
More information2017 HRS/EHRA/ECAS/APHRS/SOLAECE Expert Consensus Statement on Catheter and Surgical Ablation of Atrial Fibrillation
Summary of Expert Consensus Statement for CLINICIANS 2017 HRS/EHRA/ECAS/APHRS/SOLAECE Expert Consensus Statement on Catheter and Surgical Ablation of Atrial Fibrillation This is a summary of the Heart
More informationAtrial Fibrillation Ablation: in Whom and How
Update on Consensus Statement on Management of Atrial Fibrillation: EHRA 2012 Atrial Fibrillation Ablation: in Whom and How Update of HRS/EHRA AF/ECAS Ablation Document 2012 Anne M Gillis MD FHRS Professor
More informationClinical Value of Noninducibility by High-Dose Isoproterenol Versus Rapid Atrial Pacing After Catheter Ablation of Paroxysmal Atrial Fibrillation
13 Clinical Value of Noninducibility by High-Dose Isoproterenol Versus Rapid Atrial Pacing After Catheter Ablation of Paroxysmal Atrial Fibrillation THOMAS CRAWFORD, M.D., AMAN CHUGH, M.D., ERIC GOOD,
More informationIntegration of CT and fluoroscopy images in the ablative treatment of atrial fibrillation
Clinical applications Integration of CT and fluoroscopy images in the ablative treatment of atrial fibrillation C. Kriatselis M. Tang M. Roser J-H. erds-li E. leck Department of Internal Medicine/Cardiology,
More informationElectrical isolation of the pulmonary veins (PVs) to treat
Mechanisms of Organized Left Atrial Tachycardias Occurring After Pulmonary Vein Isolation Edward P. Gerstenfeld, MD; David J. Callans, MD; Sanjay Dixit, MD; Andrea M. Russo, MD; Hemal Nayak, MD; David
More informationCatheter ablation of atrial macro re-entrant Tachycardia - How to use 3D entrainment mapping -
Catheter ablation of atrial macro re-entrant Tachycardia - How to use 3D entrainment mapping - M. Esato, Y. Chun, G. Hindricks Kyoto Ijinkai Takeda Hosptial, Department of Arrhythmia, Japan Kyoto Koseikai
More informationAF ablation Penn experience. Optimal approach to the ablation of PAF: Importance of identifying triggers 9/25/2009
Optimal approach to the ablation of PAF: Importance of identifying triggers David J. Callans, MD University of Pennsylvania School of Medicine AF ablation Penn experience Antral (circumferential) PV ablation
More informationCatheter Ablation of Long-Standing Persistent Atrial Fibrillation
Journal of the American College of Cardiology Vol. 60, No. 19, 2012 2012 by the American College of Cardiology Foundation ISSN 0735-1097/$36.00 Published by Elsevier Inc. http://dx.doi.org/10.1016/j.jacc.2012.04.060
More informationEffect of Left Atrial Ablation on the Quality of Life in Patients With Atrial Fibrillation
Circ J 08; 72: 582 587 Effect of Left Atrial Ablation on the Quality of Life in Patients With Atrial Fibrillation Shinsuke Miyazaki, MD; Taishi Kuwahara, MD; Atsushi Takahashi, MD; Atsushi Kobori, MD;
More informationLinear Ablation Should Not Be a Standard Part of Ablation in Persistent AF. Disclosures. LA Ablation vs. Segmental Ostial Ablation With PVI for PAF
Linear Ablation Should Not Be a Standard Part of Ablation in Persistent AF The CA Heart Rhythm Symposium September 7, 2012 Gregory K. Feld, MD Professor of Medicine Director, Cardiac EP Program University
More informationCatheter ablation of scar-related atypical atrial flutter
Europace (2013) 15, 414 419 doi:10.1093/europace/eus312 CLINICAL RESEARCH Electrophysiology and ablation Catheter ablation of scar-related atypical atrial flutter James O. Coffey 1, Andre d Avila 1, Srinivas
More informationAblation of long-standing AF. Is it wise to pursue it?
Ablation of long-standing AF. Is it wise to pursue it? Carlo Pappone, MD and Vincenzo Santinelli, MD From: Department of Arrhythmology,GVM Care and Research, Cotignola, Ravenna, ITALY Address for correspondence:
More informationPeri-mitral atrial flutter in patients with atrial fibrillation ablation
Peri-mitral atrial flutter in patients with atrial fibrillation ablation Seiichiro Matsuo, MD,* Matthew Wright, MBBS, PhD,* Sébastien Knecht, MD,* Isabelle Nault, MD,* Nicolas Lellouche, MD,* Kang-Teng
More informationElectrical disconnection of pulmonary vein (PV) myocardium
Left Atrial Appendage Activity Masquerading as Pulmonary Vein Potentials Dipen Shah, MD; Michel Haissaguerre, MD; Pierre Jais, MD; Meleze Hocini, MD; Teiichi Yamane, MD; Laurent Macle, MD; Kee Joon Choi,
More informationAtrial Fibrillation: Classification and Electrophysiology. Saverio Iacopino, MD, FACC, FESC
Atrial Fibrillation: Classification and Electrophysiology Saverio Iacopino, MD, FACC, FESC Sinus Rythm Afib (first episode) AFib Paroxistic AFib Spontaneous conversion Permanent AFib Recurrence Sinus Rythm
More informationMechanism of Immediate Recurrences of Atrial Fibrillation After Restoration of Sinus Rhythm
Mechanism of Immediate Recurrences of Atrial Fibrillation After Restoration of Sinus Rhythm AMAN CHUGH, MEHMET OZAYDIN, CHRISTOPH SCHARF, STEVE W.K. LAI, BURR HALL, PETER CHEUNG, FRANK PELOSI, JR, BRADLEY
More informationAtrial Fibrillation: Catheter Ablation with New Technologies, Improving Quality of Life and Outcomes in Various Disease States
Atrial Fibrillation: Catheter Ablation with New Technologies, Improving Quality of Life and Outcomes in Various Disease States Srinivas R. Dukkipati, MD Co-Director, Cardiac Arrhythmia Service The Mount
More informationHow to Distinguish Focal Atrial Tachycardia from Small Circuits and Reentry
How to Distinguish Focal Atrial Tachycardia from Small Circuits and Reentry Pierre Jaïs; Bordeaux, France IHU LIRYC ANR-10-IAHU-04 Equipex MUSIC imaging platform ANR-11-EQPX-0030 Eutraf HEALTH-F2-2010-261057
More informationTime to recurrence of atrial fibrillation influences outcome following catheter ablation
Time to recurrence of atrial fibrillation influences outcome following catheter ablation Larraitz Gaztañaga, MD, David S. Frankel, MD, Maria Kohari, MD, Lavanya Kondapalli, MD, Erica S. Zado, PA-C, FHRS,
More informationDebate-STAR AF 2 study. PVI is not enough
Debate-STAR AF 2 study PVI is not enough Debate about STAR AF 2 trial STAR AF trial Substrate and Trigger Ablation for Reduction of Atrial Fibrillation EHJ 2010 STAR-AF 2 trial One Size Fits All? PVI is
More informationCatheter Ablation of Atrial Fibrillation in Patients with Prosthetic Mitral Valve
Catheter Ablation of Atrial Fibrillation in Patients with Prosthetic Mitral Valve Luigi Di Biase, MD, PhD, FHRS Senior Researcher Texas Cardiac Arrhythmia Institute at St. David s Medical Center, Austin,
More informationReentry in a Pulmonary Vein as a Possible Mechanism of Focal Atrial Fibrillation
824 Reentry in a Pulmonary Vein as a Possible Mechanism of Focal Atrial Fibrillation BERNARD BELHASSEN, M.D., AHARON GLICK, M.D., and SAMI VISKIN, M.D. From the Department of Cardiology, Tel-Aviv Sourasky
More informationNew Parameter to Predict Recurrence of Paroxysmal Atrial Fibrillation after Pulmonary Vein Isolation by the P-Wave Signal-Averaged Electrocardiogram
Showa Univ J Med Sci 29 2, 141 150, June 2017 Original New Parameter to Predict Recurrence of Paroxysmal Atrial Fibrillation after Pulmonary Vein Isolation by the P-Wave Signal-Averaged Electrocardiogram
More information2004 3 32 3 Chin J Cardiol, March 2004, Vol. 32 No. 3 211 4 ( ) 4 (HRA) (CS), 10 (Lasso ),, 4 (3 ) (1 ), 118,3,1, 417, ; ; The electrophysiological characteristics and ablation treatment of patients with
More informationArrhythmia/Electrophysiology
Arrhythmia/Electrophysiology Electrophysiological Findings During Ablation of Persistent Atrial Fibrillation With Electroanatomic Mapping and Double Lasso Catheter Technique Feifan Ouyang, MD; Sabine Ernst,
More informationAF Ablation in 2015 Why, Who, What and How? Steve Wilton ACC Rockies, Banff March 10, 2015
AF Ablation in 2015 Why, Who, What and How? Steve Wilton ACC Rockies, Banff March 10, 2015 Disclosures Research grant: St. Jude medical Speaking: Boehringer-Ingelheim Consulting: Arca Biopharma Learning
More informationStand alone maze: when and how?
Stand alone maze: when and how? Dong Seop Jeong Department of Thoracic and Cardiovascular Surgery, HVSI Samsung Medical Center Type of atrial fibrillation First diagnose AF Paroxysmal AF: self-terminating
More informationAtrial Tachycardia During Ongoing Atrial Fibrillation Ablation
Circulation Journal Official Journal of the Japanese Circulation Society http://www.j-circ.or.jp Advance Publication by J-STAGE Atrial Tachycardia During Ongoing Atrial Fibrillation Ablation EnSite Array
More informationSupplementary Online Content
Supplementary Online Content Verma A, Champagne J, Sapp J, et al. Asymptomatic episodes of atrial fibrillation before and after catheter ablation: a prospective, multicenter study. JAMA Intern Med. Published
More informationCase Report Successful Multi-chamber Catheter Ablation of Persistent Atrial Fibrillation in Cor Triatriatum Sinister
www.ipej.org 50 Case Report Successful Multi-chamber Catheter Ablation of Persistent Atrial Fibrillation in Cor Triatriatum Sinister Andrew Gavin, MBChB 1, Cameron B Singleton, MD 1, Andrew D McGavigan,
More informationCatheter Ablation of Atrial Fibrillation Strategy and Outcome Predictors Shih-Ann Chen MD
Catheter Ablation of Atrial Fibrillation Strategy and Outcome Predictors Shih-Ann Chen MD Taipei Veterans General Hospital, Taiwan Outline of AF Ablation 1. Strategy for Catheter Ablation of AF 2. Substrate
More informationIs cardioversion old hat? What is new in interventional treatment of AF symptoms?
Is cardioversion old hat? What is new in interventional treatment of AF symptoms? Joseph de Bono Consultant Electrophysiologist University Hospitals Birmingham Atrial Fibrillation (AF) Affects 2% of the
More informationAnkara, Turkey 2 Department of Cardiology, Division of Arrhythmia and Electrophysiology, Yuksek Ihtisas
258 Case Report Electroanatomic Mapping-Guided Radiofrequency Ablation of Adenosine Sensitive Incessant Focal Atrial Tachycardia Originating from the Non-Coronary Aortic Cusp in a Child Serhat Koca, MD
More informationHybrid Ablation of AF in the Operating Room: Is There a Need? MAZE III Procedure. Spectrum of Atrial Fibrillation
Hybrid Ablation of AF in the Operating Room: Is There a Need? MAZE III Procedure Paul J. Wang, MD Amin Al-Ahmad, MD Gan Dunnington, MD Stanford University Cox J, et al. Ann Thorac Surg. 1993;55:578-580.
More informationThe pulmonary veins have been demonstrated to often
Pulmonary Vein Isolation for Paroxysmal and Persistent Atrial Fibrillation Hakan Oral, MD; Bradley P. Knight, MD; Hiroshi Tada, MD; Mehmet Özaydın, MD; Aman Chugh, MD; Sohail Hassan, MD; Christoph Scharf,
More informationPercutaneous Transvenous Atrial Fibrillation Ablation and Stroke
Percutaneous Transvenous Atrial Fibrillation Ablation and Stroke Vivek Y. Reddy, MD Helmsley Trust Professor of Medicine Director, Cardiac Arrhythmia Service The Mount Sinai Hospital Disclosures Grant
More informationFrom the Division of Cardiology, Department of Internal Medicine, University of Michigan Medical Center, Ann Arbor, Michigan
118 Reprinted with permission from JOURNAL OF CARDIOVASCULAR ELECTROPHYSIOLOGY, Volume 13, No. 2, February 2002 Copyright 2002 by Futura Publishing Company, Inc., Armonk, NY 10504-0418 Differentiation
More informationRaphael Rosso MD, Yuval Levi Med. Eng., Sami Viskin MD Tel Aviv Sourasky Medical Center
Radiofrequency Ablation of Atrial Fibrillation: Comparison of Success Rate of Circular Ablation vs Point-by-Point Ablation with Contact Force Assessment in Paroxysmal and Persistent Atrial Fibrillation
More informationΚατάλυση παροξυσμικής κολπικής μαρμαρυγής Ποια τεχνολογία και σε ποιους ασθενείς; Χάρης Κοσσυβάκης Καρδιολογικό Τμήμα Γ.Ν.Α. «Γ.
Κατάλυση παροξυσμικής κολπικής μαρμαρυγής Ποια τεχνολογία και σε ποιους ασθενείς; Χάρης Κοσσυβάκης Καρδιολογικό Τμήμα Γ.Ν.Α. «Γ. ΓΕΝΝΗΜΑΤΑΣ» Rhythm control antiarrhythmic drugs vs catheter ablation Summary
More informationΕπιπλοκές κατάλυσης πνευµονικών φλεβών
Επιπλοκές κατάλυσης πνευµονικών φλεβών Παναγιώτης Ιωαννίδης Διευθυντής Τµήµατος Αρρυθµιών & Επεµβατικής Ηλεκτροφυσιολογίας Βιοκλινικής Αθηνών ΣΕΜΙΝΑΡΙΑ ΟΜΑΔΩΝ ΕΡΓΑΣΙΑΣ Ιωάννινα, 27-2-2015 Solving an equation
More informationCatheter-Induced Linear Lesions in the Left Atrium in Patients With Atrial Fibrillation An Electroanatomic Study
Journal of the American College of Cardiology Vol. 42, No. 7, 2003 2003 by the American College of Cardiology Foundation ISSN 0735-1097/03/$30.00 Published by Elsevier Inc. doi:10.1016/s0735-1097(03)00940-9
More informationAtrial Fibrillation: Electrophysiological Mechanisms and the Results of Interventional Therapy
Vol. 8, No. 3, September 2003 185 Atrial Fibrillation: Electrophysiological Mechanisms and the Results of Interventional Therapy A.SH. REVISHVILI Bakoulev Research Centre for Cardiovascular Surgery, Russian
More information1995 Our First AF Ablation. Atrial Tachycardias During and After Atrial Fibrillation Ablation. Left Atrial Flutter. 13 Hours Later 9/25/2009
1995 Our First AF Ablation Atrial Tachycardias During and After Atrial Fibrillation Ablation G. Neal Kay MD University of Alabama at Birmingham Right Anterior Oblique Left Anterior Oblique Left Atrial
More informationAF Today: W. For the majority of patients with atrial. are the Options? Chris Case
AF Today: W hat are the Options? Management strategies for patients with atrial fibrillation should depend on the individual patient. Treatment with medications seems adequate for most patients with atrial
More informationArrhythmia/Electrophysiology
Arrhythmia/Electrophysiology Recovered Pulmonary Vein Conduction as a Dominant Factor for Recurrent Atrial Tachyarrhythmias After Complete Circular Isolation of the Pulmonary Veins Lessons From Double
More informationThe Who, What, Why, and How-To Guide for Circumferential Pulmonary Vein Ablation
1226 TECHNIQUES AND TECHNOLOGY Editor: Hugh Calkins, M.D. The Who, What, Why, and How-To Guide for Circumferential Pulmonary Vein Ablation CARLO PAPPONE, M.D., PH.D., and VINCENZO SANTINELLI, M.D. From
More informationHow to ablate typical atrial flutter
Europace (1999) 1, 151 155 HOW TO... SERIES How to ablate typical atrial flutter A. Takahashi, D. C. Shah, P. Jaïs and M. Haïssaguerre Electrophysiologie Cardiaque, Hopital Cardiologique du Haut-Lévêque,
More informationCase Report. Sumito Narita MD 1;3, Takeshi Tsuchiya MD, PhD 1, Hiroya Ushinohama MD, PhD 2, Shin-ichi Ando MD, PhD 3
Case Report Identification and Radiofrequency Catheter Ablation of a Nonsustained Atrial Tachycardia at the Septal Mitral Annulus with the Use of a Noncontact Mapping System: A Case Report Sumito Narita
More informationEffects of Stepwise Ablation of Chronic Atrial Fibrillation on Atrial Electrical and Mechanical Properties
Journal of the American College of Cardiology Vol. 49, No. 12, 2007 2007 by the American College of Cardiology Foundation ISSN 0735-1097/07/$32.00 Published by Elsevier Inc. doi:10.1016/j.jacc.2006.11.033
More informationEvidence for Longitudinal and Transverse Fiber Conduction in Human Pulmonary Veins
Evidence for Longitudinal and Transverse Fiber Conduction in Human Pulmonary Veins Relevance for Catheter Ablation Javier E. Sanchez, MD; Vance J. Plumb, MD; Andrew E. Epstein, MD; G. Neal Kay, MD Background
More informationUNmasking Dormant Electrical Reconduction by Adenosine TriPhosphate
KPAF trial The Kansai Plus Atrial Fibrillation (KPAF) trial is a 2x2 factorial randomized controlled trial, composed of the UNDER-ATP and EAST-AF trials. Efficacy of adenosine triphosphate guided ablation
More informationThe impact of hypertension on the electromechanical properties and outcome of catheter ablation in atrial fibrillation patients
Original Article The impact of hypertension on the electromechanical properties and outcome of catheter ablation in atrial fibrillation patients Tao Wang 1, Yun-Long Xia 1, Shu-Long Zhang 1, Lian-Jun Gao
More informationCase Report Figure-8 Tachycardia Confined to the Anterior Wall of the Left Atrium
www.ipej.org 146 Case Report Figure-8 Tachycardia Confined to the Anterior Wall of the Left Atrium Ioan Liuba, M.D., Anders Jönsson, M.D., Håkan Walfridsson, M.D. Department of Cardiology, Heartcenter,
More informationTime to Cardioversion of Recurrent Atrial Arrhythmias After Catheter Ablation of Atrial Fibrillation and Long-Term Clinical Outcome
Time to Cardioversion of Recurrent Atrial Arrhythmias After Catheter Ablation of Atrial Fibrillation and Long-Term Clinical Outcome TIMIR S. BAMAN, M.D., SANJAYA K. GUPTA, M.D., SREEDHAR R. BILLAKANTY,
More informationLong-Term Outcomes After Cryoballoon Pulmonary Vein Isolation
Journal of the American College of Cardiology Vol. 61, No. 16, 2013 2013 by the American College of Cardiology Foundation ISSN 0735-1097/$36.00 Published by Elsevier Inc. http://dx.doi.org/10.1016/j.jacc.2012.09.033
More informationThe EP Perspective: Should We Do Hybrid Ablation, and Who Should We Do It On?
The EP Perspective: Should We Do Hybrid Ablation, and Who Should We Do It On? L. Pison, MD PhD FESC AATS Surgical Treatment of Arrhythmias and Rhythm Disorders November 17-18, 2017 Miami Beach, FL, USA
More informationTrigger Activity More Than Three Years After Left Atrial Linear Ablation Without Pulmonary Vein Isolation in Patients With Atrial Fibrillation
Journal of the American College of Cardiology Vol. 46, No. 2, 2005 2005 by the American College of Cardiology Foundation ISSN 0735-1097/05/$30.00 Published by Elsevier Inc. doi:10.1016/j.jacc.2005.03.063
More informationINTRODUCTION. Key Words:
Original Article Acta Cardiol Sin 2015;31:317 324 doi: 10.6515/ACS20141218A EPS and Arrhythmia The Electrical Characteristics and Clinical Significance of the Effect of Adenosine on Dissociated Activity
More informationAtrial fibrillation (AF), the most sustained cardiac arrhythmia
Difference Between Dormant Conduction Sites Revealed by Adenosine Triphosphate Provocation and Unipolar Pace-Capture Sites Along the Ablation Line After Pulmonary Vein Isolation Rikitake Kogawa, 1 MD,
More informationA New Approach for Catheter Ablation of Atrial Fibrillation: Mapping of the Electrophysiologic Substrate
Journal of the American College of Cardiology Vol. 43, No. 11, 2004 2004 by the American College of Cardiology Foundation ISSN 0735-1097/04/$30.00 Published by Elsevier Inc. doi:10.1016/j.jacc.2003.12.054
More informationABLATION TECHNIQUES FOR ATRIAL FIBRILLATION
ABLATION TECHNIQUES FOR ATRIAL FIBRILLATION Demosthenes G. Katritsis, MD, PhD(Lon), FRCP Athens Euroclinic Ablation for AF Cox JL, et al. Surgery for atrial fibrillation. Semin Thorac Cardiovasc Surg.
More informationComparative Effectiveness of Radiofrequency Catheter Ablation for Atrial Fibrillation Executive Summary
Number 15 Effective Health Care Comparative Effectiveness of Radiofrequency Catheter Ablation for Atrial Fibrillation Executive Summary Background The Agency for Healthcare Research and Quality commissioned
More informationRole of LAA isolation in AF cure
MAM 2017, Zurich Role of LAA isolation in AF cure Sakis Themistoclakis, MD Director, Unit of Electrophysiology and Cardiac Pacing Department of Cardiothoracic & Vascular Medicine Ospedale dell Angelo,
More informationA Cryo Anatomical Procedure to Everyone? Saverio Iacopino, FACC, FESC
A Cryo Anatomical Procedure to Everyone? Saverio Iacopino, FACC, FESC AF Clinical/Referral Challenge Asymptomatic 40% 3 Rx Effective 30% Failed Rx Ablation Atrial fibrillation (AF) is the most common Candidate
More informationIntroduction. Methods
Europace (2015) 17, 801 806 doi:10.1093/europace/euu332 CLINICAL RESEARCH Cardiac electrophysiology Electrophysiological studies in patients with paroxysmal supraventricular tachycardias but no electrocardiogram
More informationAlthough circumferential pulmonary vein ablation
Circumferential Pulmonary Vein Ablation With Additional Linear Ablation Results in an Increased Incidence of Left Atrial Flutter Compared With Segmental Pulmonary Vein Isolation as an Initial Approach
More informationCardiology Department, Ain Shams University, Cairo, Egypt.
Early Pulmonary Vein Conduction Recovery After Catheter Ablation Of Atrial Fibrillation Ayman Mortada 1, Saeed Khaled 1, Samir Wafa 1, Hayam Eldamanhoury 1, Ahmed Nabil 1 1 Cardiology Department, Ain Shams
More informationPost-ablation Management: Drug therapy, Anticoagulation and long-term Monitoring
Catheter Ablation of Atrial Fibrillation: State of the Art Post-ablation Management: Drug therapy, Anticoagulation and long-term Monitoring Dipen Shah Service de Cardiologie Hospital Cantonal de Genève
More informationMapping techniques in AFib. Helmut Pürerfellner, MD Public Hospital Elisabethinen Academic Teaching Hospital Linz, Austria
Mapping techniques in AFib Helmut Pürerfellner, MD Public Hospital Elisabethinen Academic Teaching Hospital Linz, Austria critical zone Microreeentrant circuits LOM PV foci Sueda Ann Thorac Surg 1997 Haissaguerre
More informationWhat is an O.R. Report? BY STEVE S. RYAN, PhD
BY STEVE S. RYAN, PhD Steve is a former A-Fib patient, publisher of the non-profit patient education website, Atrial Fibrillation: Resources for Patients, (A- Fib.com), author of the award-winning book,
More informationAtrial fibrillation (AF) is the most common arrhythmia in
Distinctive Electrophysiological Properties of Pulmonary Veins in Patients With Atrial Fibrillation Pierre Jaïs, MD; Mélèze Hocini, MD; Laurent Macle, MD; Kee-Joon Choi, MD; Isabel Deisenhofer, MD; Rukshen
More informationCatheter Ablation for Atrial Fibrillation: Patient Selection and Outcomes
Catheter Ablation for Atrial Fibrillation: Patient Selection and Outcomes Francis Marchlinski, MD Richard T and Angela Clark President s Distinguished Professor Director Cardiac Electrophysiolgy University
More informationCARDIOINSIGHT TM NONINVASIVE 3D MAPPING SYSTEM CLINICAL EVIDENCE SUMMARY
CARDIOINSIGHT TM NONINVASIVE 3D MAPPING SYSTEM CLINICAL EVIDENCE SUMMARY April 2017 SUPPORTING EVIDENCE RHYTHM AF VT PUBLICATIONS Driver Domains in Persistent Atrial Fibrillation (Haissaiguerre, et al)
More informationRadiofrequency catheter ablation for paroxysmal atrial fibrillation: outcomes during a 3-year follow-up period
Clinical Research Report Radiofrequency catheter ablation for paroxysmal atrial fibrillation: outcomes during a 3-year follow-up period Journal of International Medical Research 2019, Vol. 47(4) 1636 1648!
More informationCharacteristics of Rapid Rhythms Recorded Within Pulmonary Veins During Atrial Fibrillation
Characteristics of Rapid Rhythms Recorded Within Pulmonary Veins During Atrial Fibrillation HIROSHI TADA, MEHMET ÖZAYDIN, HAKAN ORAL, BRADLEY P. KNIGHT, AMAN CHUGH, CHRISTOPH SCHARF, FRANK PELOSI, Jr.,
More informationCase Report Electroanatomical Mapping and Ablation of Upper Loop Reentry Atrial Flutter
Hellenic J Cardiol 46: 74-78, 2005 Case Report Electroanatomical Mapping and blation of Upper Loop Reentry trial Flutter POSTOLOS KTSIVS, PNGIOTIS IONNIDIS, CHRLMOS VSSILOPOULOS, THIN GIOTOPOULOU, THNSIOS
More informationCatheter Ablation: Atrial fibrillation (AF) is the most common. Another Option for AF FAQ. Who performs ablation for treatment of AF?
: Another Option for AF Atrial fibrillation (AF) is a highly common cardiac arrhythmia and a major risk factor for stroke. In this article, Dr. Khan and Dr. Skanes detail how catheter ablation significantly
More informationAblation of persistent AF Is it different than paroxysmal?
Ablation of persistent AF Is it different than paroxysmal? Steven J. Kalbfleisch, MD Medical Director Electrophysiology Laboratory Ohio State University Wexner Medical Center Ross Heart Hospital Columbus,
More informationPoint of View Ablation Of Atrial Flutter:Block (Isthmus Conduction) Or Not A Block, That Is The Question?
www.ipej.org 85 Point of View Ablation Of Atrial Flutter:Block (Isthmus Conduction) Or Not A Block, That Is The Question? Ashish Nabar, MD, PhD Address for correspondence: Ashish Nabar MD, PhD, Department
More informationThe major thoracic veins, with their specific electrical
Atrial Fibrillation Originating From Persistent Left Superior Vena Cava Li-Fern Hsu, MBBS; Pierre Jaïs, MD; David Keane, MD; J. Marcus Wharton, MD; Isabel Deisenhofer, MD; Mélèze Hocini, MD; Dipen C. Shah,
More informationNationwide Survey of Catheter Ablation for Atrial Fibrillation: The Japanese Catheter Ablation Registry of Atrial Fibrillation (J-CARAF)
Circulation Journal Official Journal of the Japanese Circulation Society http://www.j-circ.or.jp LATE BREAKING COHORT STUDIES (JCS 2014) Nationwide Survey of Catheter Ablation for Atrial Fibrillation:
More informationCatheter Ablation for Persistent Atrial Fibrillation
Catheter Ablation for Persistent Atrial Fibrillation Saeed Oraii MD, Cardiologist Interventional Electrophysiologist Tehran Arrhythmia Clinic April 2016 Atrial Fibrillation First reported by Sir William
More informationCircumferential Pulmonary-Vein Ablation for Chronic Atrial Fibrillation
The new england journal of medicine original article Circumferential Pulmonary-Vein Ablation for Chronic Atrial Fibrillation Hakan Oral, M.D., Carlo Pappone, M.D., Aman Chugh, M.D., Eric Good, D.O., Frank
More informationAccepted Manuscript. Inadvertent Atrial Dissociation Following Catheter Ablation: A Demonstration of Cardiac Anisotropy and Functional Block
Accepted Manuscript Inadvertent Atrial Dissociation Following Catheter Ablation: A Demonstration of Cardiac Anisotropy and Functional Block Shashank Jain, MD, Sajid Mirza, MD, Gunjan Shukla, MD, FHRS PII:
More informationOriginal Article Short- and long-term experience in pulmonary vein segmental ostial ablation for paroxysmal atrial fibrillation*
www.ipej.org 6 Original Article Short- and long-term experience in pulmonary vein segmental ostial ablation for paroxysmal atrial fibrillation* *English version of "Langzeit-Ergebnisse der ostialen Pulmonalvenenisolation
More information